Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 17 de 17
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Front Sports Act Living ; 5: 1236112, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37886220

RESUMO

Introduction: This study aims to (1) determine the average and most demanding passage (MDP) load of national-level female soccer matches and (2) evaluate the relationship between average and MDP load during small-sided games (SSGs), large-sided games (LSGs), and matches. Methods: A total of 37 national-level female soccer players from a single club senior team and the U18 team participated. The average and 1-, 3-, and 5-min MDP external (total, high-speed, and very-high-speed running distances, acceleration and deceleration distances, average metabolic power, and high-metabolic load distance) and internal loads (average heart rate, rate of perceived exertion) of the 29 league matches, ten 4 vs. 4 + goalkeepers SSGs, and six 8 vs. 8 + goalkeepers LSGs were analyzed by the Polar Team Pro player tracking system. Results: In matches, the external load variables during 1-, 3-, and 5-min MDPs were 167%-1,165%, 135%-504%, and 126%-359%, of match average values, respectively. In LSGs, all external load variables reached higher average values compared with those during matches, except for the very-high-speed running distance; however, no variable reached higher values of 1-min MDP compared with those during the matches. In SSGs, the average acceleration and deceleration distances were higher compared with those during the matches. Discussion: The findings from the present study suggest that LSGs and SSGs can be used to overload the average values of the selected external load variables compared with those during the matches; however, other training options must be explored to overload 1-min match MDPs.

2.
Eur J Vasc Endovasc Surg ; 51(4): 511-6, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-26854209

RESUMO

OBJECTIVES: The objective of this study was to identify the proportion of abdominal aortic aneurysm ruptures that occur before the screening age or threshold diameter for operative repair is reached. METHODS: The study was a retrospective analysis of RAAA patients including all RAAA patients admitted to Helsinki (HUH) and Tampere University Hospitals (TaUH) during 2002-2013. The data for age, gender, and comorbidities were collected from vascular registry and patient records. Computed tomography images taken at the time of admission were used for the measurement of maximum anteroposterior (AP) aneurysm diameter at the time of rupture. Age and diameter data were compared with risk factors. RESULTS: A total of 585 patients diagnosed with RAAA were admitted to the two hospitals during the 12 year period. The mean age at the time of rupture was 73.6 years (SD 9.5, range 42-96 years). 18.3% of patients were under 65: 21.4% of men and 3.0% of women. Men were on average 8 years younger than women. The odds ratio (OR) for rupture before 65 years of age for smokers was 2.1 compared with non-smokers, and 28.4% of smokers were under 65 at the time of rupture. Of all RAAA patients, 327 had a computed tomography scan confirming rupture. The mean AP diameter of the aneurysm was 75.6 mm (SD 15.8, range 32-155 mm). The mean size was significantly lower in women than in men (70.5 vs. 76.8, p = .005). CONCLUSIONS: The data from this study show that a fifth of men would not make it to the screening age of 65 before AAA rupture, the proportion being even larger in active smokers. The data from this study also supports the previous finding that aneurysm size at the time of rupture is significantly smaller in women.


Assuntos
Aneurisma da Aorta Abdominal/epidemiologia , Ruptura Aórtica/epidemiologia , Programas de Rastreamento , Adulto , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Aneurisma da Aorta Abdominal/diagnóstico por imagem , Aneurisma da Aorta Abdominal/cirurgia , Ruptura Aórtica/diagnóstico por imagem , Ruptura Aórtica/cirurgia , Aortografia/métodos , Procedimentos Cirúrgicos Eletivos , Feminino , Finlândia/epidemiologia , Humanos , Modelos Logísticos , Masculino , Programas de Rastreamento/métodos , Pessoa de Meia-Idade , Análise Multivariada , Razão de Chances , Valor Preditivo dos Testes , Estudos Retrospectivos , Fatores de Risco , Fatores Sexuais , Fumar/efeitos adversos , Fumar/epidemiologia , Tomografia Computadorizada por Raios X , Procedimentos Cirúrgicos Vasculares
3.
Clin Nephrol ; 75(6): 550-6, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21612760

RESUMO

AIMS: Nephropathia epidemica (NE) is mild type of hemorrhagic fever caused by Puumala (PUU) hantavirus. Renal biopsy typically shows acute tubulointerstitial nephritis and complete recovery is the usual outcome. We previously described 5 patients with membranoproliferative glomerulonephritis (MPGN) after acute NE. We now report on 7 more patients who developed biopsy-confirmed glomerulonephritis (GN) during the convalescent phase of NE. MATERIAL AND METHODS: We present case histories of 7 patients with nephrotic-range proteinuria concomitant with hematuria after serologically verified NE. RESULTS: Renal biopsy specimens disclosed MPGN in 5 patients, membranous GN (MGN) in 1 and mesangial GN (MesGN) in 1. All patients achieved remission of nephrotic syndrome within a median time of 0.6 years (range 0.5 - 5.5 y). The median follow-up time was 1.7 years (0.7 - 15.6 y). CONCLUSIONS: As a rare phenomenon, nephrotic syndrome may emerge during the convalescent phase of acute PUU hantavirus infection. In most cases the prognosis of GN caused by NE seems to be favorable.


Assuntos
Glomerulonefrite Membranoproliferativa/virologia , Febre Hemorrágica com Síndrome Renal/complicações , Virus Puumala , Adulto , Biópsia , Feminino , Finlândia , Glomerulonefrite Membranoproliferativa/diagnóstico , Glomerulonefrite Membranoproliferativa/tratamento farmacológico , Humanos , Masculino , Pessoa de Meia-Idade
4.
Percept Mot Skills ; 110(3 Pt 1): 675-92, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20681323

RESUMO

This study of perceptual and motor skills in soccer players was conducted on adolescent males. The goals were to monitor the development of general perceptual motor skills in nonsoccer-playing and soccer-playing groups (n = 245), to examine the relationship between physical maturity and general perceptual motor skills (n = 41), and to compare the differences in general perceptual motor skills between groups with different soccer expertise (n = 142). The measured variables were simple reaction time, peripheral awareness, eye-hand-foot coordination, and testosterone blood level. The results suggested that general perceptual motor skills improved with age, the development of these skills was related to participants' blood testosterone concentration (especially between 12 and 14 years), and general perceptual motor skills improved with soccer expertise. However, the differences between subelite and elite soccer players were not meaningful enough to encourage practitioners to test general perceptual motor skills on a large scale when evaluating the potential of young players.


Assuntos
Desempenho Atlético , Prática Psicológica , Psicologia do Adolescente , Desempenho Psicomotor , Futebol/psicologia , Adolescente , Fatores Etários , Conscientização/fisiologia , Criança , Humanos , Masculino , Orientação/fisiologia , Desempenho Psicomotor/fisiologia , Tempo de Reação/fisiologia , Futebol/fisiologia , Testosterona/sangue , Campos Visuais/fisiologia
5.
J Endocrinol ; 178(3): 479-89, 2003 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12967339

RESUMO

Activins and inhibins are structurally related glycoprotein hormones modulating pituitary FSH secretion and gonadal steroidogenesis. Activins and inhibins are also produced in the adrenal cortex where their physiological role is poorly known. Hormonally active human adrenocortical tumors express and secrete inhibins, while in mice adrenal inhibins may function as tumor suppressors. To clarify the significance of adrenal activins and inhibins we investigated the localization of activin/inhibin signaling components in the adrenal gland, and the effects of activins and inhibins on adrenocortical steroidogenesis and apoptosis. Activin receptor type II/IIB and IB, activin signal transduction proteins Smad2/3, and inhibin receptor betaglycan were expressed throughout the adrenal cortex, whereas Smad4 expression was seen mainly in the zona reticularis and the innermost zona fasciculata as evaluated by immunohistochemistry. Treatment of cultured adrenocortical carcinoma NCI-H295R cells with activin A inhibited steroidogenic acute regulatory protein and 17alpha-hydroxylase/17,20-lyase mRNA accumulation as evaluated by the Northern blot technique, and decreased cortisol, androstenedione, dehydroepiandrosterone and dehydroepiandrosterone sulfate secretion as determined by specific enzyme immunoassays. Activin A increased apoptosis as measured by a terminal deoxynucleotidyl transferase in situ apoptosis detection method. Inhibins had no effect on steroidogenesis or apoptosis. In summary, activin/inhibin signaling components are coexpressed in the zona reticularis and the innermost zona fasciculata indicating full signaling potential for adrenal activins and inhibins in these layers. Activin inhibits steroidogenic enzyme gene expression and steroid secretion, and increases apoptosis in human adrenocortical cells. Thus, the activin-inhibin system may have a significant role in the regulation of glucocorticoid and androgen production and apoptotic cell death in the human adrenal cortex.


Assuntos
Ativinas/análise , Glândulas Suprarrenais/metabolismo , Hormônio Adrenocorticotrópico/biossíntese , Inibinas/análise , Proteínas , Transdução de Sinais/fisiologia , Receptores de Ativinas Tipo I/análise , Receptores de Activinas Tipo II/análise , Ativinas/genética , Ativinas/farmacologia , Corticosteroides/biossíntese , Glândulas Suprarrenais/química , Glândulas Suprarrenais/citologia , Adulto , Apoptose , Northern Blotting/métodos , Linhagem Celular Tumoral , Fragmentação do DNA , Proteínas de Ligação a DNA/análise , Proteínas de Ligação a DNA/genética , Humanos , Inibinas/genética , Inibinas/farmacologia , Proteoglicanas/análise , Proteoglicanas/genética , RNA Mensageiro/análise , Receptores de Fatores de Crescimento Transformadores beta/análise , Receptores de Fatores de Crescimento Transformadores beta/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Proteína Smad2 , Estatísticas não Paramétricas , Transativadores/análise , Transativadores/genética , Zona Fasciculada/química , Zona Fasciculada/metabolismo , Zona Reticular/química , Zona Reticular/metabolismo
6.
Mol Hum Reprod ; 8(11): 992-7, 2002 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-12397211

RESUMO

Activin and its binding protein follistatin may act as local regulators of cell growth and steroidogenesis in the human ovary. The recently identified follistatin-related gene (FLRG) is expressed abundantly in the human ovary, has high affinity for activin, and is able to inhibit activin-induced transcriptional responses. However, little is known about the regulation of FLRG expression in specific cell types in the ovary, while it is known that gonadotrophins induce follistatin gene expression in human granulosa-luteal cells. In this study, we investigated the expression of FLRG mRNA in granulosa-luteal cells of preovulatory follicles obtained from women undergoing IVF. FLRG mRNA was detected by RT-PCR in fresh and cultured granulosa-luteal cells, as well as in normal ovarian stroma, theca and granulosa cells. Northern blot analysis revealed a 2.5 kb transcript of the FLRG in cultured granulosa-luteal cells. The protein kinase C activator, 12-O-tetradecanoyl phorbol 13-acetate (TPA, 160 nmol/l), and prostaglandin E(2) (PGE(2), 1 micromol/l) increased FLRG mRNA accumulation up to 3-8 fold over the control level after 24 h of treatment, and these stimulatory effects were dose-dependent. Co-treatment with the protein kinase C inhibitor, Ro-31-8220 (3 micromol/l), blocked the stimulatory effect of TPA. Although short term treatment with the protein kinase A activator, (Bu)(2)cAMP (1 mmol/l), slightly reduced FLRG mRNA expression in most experiments, long term treatment with FSH (100 IU/l), LH (100 IU/l), or (Bu)(2)cAMP had no significant effect on the FLRG mRNA levels. As expected, gonadotrophins, protein kinase A and C activators and PGE(2) increased granulosa-luteal cell progesterone secretion into the culture media. Taken together, previous and our present data suggest that protein kinase C and A signal transduction pathways differently regulate the expression of FLRG and follistatin genes in human ovarian granulosa-luteal cells.


Assuntos
Dinoprostona/metabolismo , Proteínas Relacionadas à Folistatina/genética , Regulação da Expressão Gênica , Células Lúteas/fisiologia , Proteína Quinase C/metabolismo , Bucladesina/farmacologia , Células Cultivadas , Dinoprostona/farmacologia , Relação Dose-Resposta a Droga , Ativação Enzimática/efeitos dos fármacos , Inibidores Enzimáticos/farmacologia , Feminino , Hormônio Foliculoestimulante/farmacologia , Proteínas Relacionadas à Folistatina/efeitos dos fármacos , Proteínas Relacionadas à Folistatina/metabolismo , Humanos , Indóis/farmacologia , Células Lúteas/citologia , Células Lúteas/efeitos dos fármacos , Hormônio Luteinizante/farmacologia , Ovário/fisiologia , Progesterona/metabolismo , Proteína Quinase C/antagonistas & inibidores , RNA Mensageiro/metabolismo , Proteínas Recombinantes/farmacologia , Transdução de Sinais , Acetato de Tetradecanoilforbol/farmacologia
7.
J Endocrinol ; 172(3): 557-63, 2002 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-11874704

RESUMO

Pituitary gonadotropins mediate part of their effects on ovarian function via local hormones and growth factors produced by granulosa cells. Activins and inhibins are among these factors, and they have often opposite effects on various components of the reproductive system. The purpose of this study was to investigate the regulation of ovarian activin A secretion using cultured human ovarian granulosa-luteal cells as a model. The granulosa-luteal cells, obtained from women taking part in an in vitro fertilization program, were cultured and treated with FSH, LH, 8-bromo cAMP (8-BrcAMP, a protein kinase A activator) and 12-O-tetradecanoyl phorbol-13-acetate (TPA, a protein kinase C activator). Conditioned cell culture media were analyzed for activin A, inhibin A and progesterone concentrations with specific enzyme immunoassays. FSH and LH (1-100 IU/l) increased activin A secretion with 24 h of treatment (to 132% and 253% of control respectively; P<0.05 for both), but their effects were inhibitory in 48-h treatments (26% and 16% decreases respectively; P<0.05 for both). In the same experiments, FSH and LH increased inhibin A and progesterone secretion after both 24 and 48 h of treatment. 8-BrcAMP (0.1-100 muM) increased activin A in 24- and 48-h experiments (to 206% and 148% of control respectively; P<0.01 for both). Inhibin A and progesterone secretion were stimulated by 8-BrcAMP time- and dose-dependently. TPA increased activin A secretion dose-dependently (0.1-100 ng/ml) in both 24- and 48-h experiments. At 100 ng/ml concentration, it increased activin A up to 61-fold and inhibin A up to 16-fold of control in 24-h experiments. We conclude that gonadotropins regulate immunoreactive activin A secretion biphasically in cultured human granulosa-luteal cells: initial stimulation is followed by inhibition. In contrast, gonadotropins increase inhibin A and progesterone secretion continuously. Consequently, continuing gonadotropin stimulation leads to a decreasing activin:inhibin ratio, which may have a significant role in the local fine-tuning of ovarian steroidogenesis.


Assuntos
Ativinas/metabolismo , Gonadotropinas Hipofisárias/farmacologia , Células da Granulosa/metabolismo , Subunidades beta de Inibinas/metabolismo , Inibinas/metabolismo , 8-Bromo Monofosfato de Adenosina Cíclica/farmacologia , Células Cultivadas , Proteínas Quinases Dependentes de AMP Cíclico/metabolismo , Relação Dose-Resposta a Droga , Ativação Enzimática , Feminino , Hormônio Foliculoestimulante/farmacologia , Células da Granulosa/efeitos dos fármacos , Humanos , Hormônio Luteinizante/farmacologia , Progesterona/metabolismo , Proteína Quinase C/metabolismo , Taxa Secretória/efeitos dos fármacos , Estatísticas não Paramétricas , Estimulação Química , Acetato de Tetradecanoilforbol/farmacologia , Fatores de Tempo
8.
J Endocrinol ; 167(2): 289-94, 2000 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11054643

RESUMO

Inhibins are gonadal glycoproteins with endocrine effects on pituitary FSH secretion and para/autocrine effects on ovarian and testicular function. The purpose of this study was to investigate the endocrine and para/autocrine regulation of inhibin A and inhibin B secretion in human ovarian granulosa-luteal cells. The cells were obtained from women undergoing in vitro fertilization, and the primary cultures were treated with FSH, LH, human chorionic gonadotropin (hCG), activin A, 8-bromo cyclic AMP (8-BrcAMP), staurosporine (a protein kinase C inhibitor) and an antagonist of IGF action (type-1 IGF receptor antibody alpha IR3). The secretion of inhibins was measured by ELISA assays capable of reliably distinguishing between inhibin A and B. FSH, LH, hCG and 8-BrcAMP increased inhibin A secretion on average up to 180% (P<0.01), 192% (P<0.05), 210% (P<0.01) and 243% (P<0.01) respectively of the control level, while their stimulatory effect on inhibin B secretion was less pronounced (up to 167%, P<0.01; 139%, P<0.05; 127%, P>0.05; 133%, P>0.05 of the controls respectively). alpha IR3 decreased inhibin A and B secretion down to 70% (P<0.01) and 50% (P<0.01) respectively of the control. Staurosporine decreased inhibin B secretion down to 49% (P<0.01) of the control; its effect on inhibin A secretion was not significant. Activin A increased inhibin B secretion up to fourfold of the control (P<0.05) while its effect on inhibin A secretion was insignificant. We conclude that gonadotropins via the protein kinase A signal transduction pathway are the main positive regulators of inhibin A and B secretion in human granulosa-luteal cells. The protein kinase C signal transduction pathway seems to be important especially for inhibin B secretion. Locally produced IGFs are probably important inducers of the production of both forms of inhibin in human ovaries while activins seem to upregulate inhibin B secretion.


Assuntos
Corpo Lúteo/metabolismo , Gonadotropinas/farmacologia , Células da Granulosa/metabolismo , Inibinas/metabolismo , Ativinas , Técnicas de Cultura de Células , Gonadotropina Coriônica/farmacologia , Corpo Lúteo/citologia , Proteínas Quinases Dependentes de AMP Cíclico/fisiologia , Feminino , Hormônio Foliculoestimulante/farmacologia , Humanos , Inibinas/farmacologia , Hormônio Luteinizante/farmacologia , Proteína Quinase C/fisiologia , Receptor IGF Tipo 1/metabolismo , Proteínas Recombinantes/farmacologia , Transdução de Sinais/fisiologia
13.
Clin Nephrol ; 27(4): 163-8, 1987 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-3555908

RESUMO

Eighteen patients with chronic renal failure (serum creatinine 173-756 mumol/l) and hyperlipidemia were treated with gemfibrozil (1200 mg/day). The drug caused a significant improvement of the dyslipidemia within one week and the effect was progressive during the 28 weeks of treatment. Very-low-density lipoprotein triglycerides and very-low-density lipoprotein cholesterol decreased by about 50% and high-density lipoprotein cholesterol increased by 30%. The lipoprotein changes occurred simultaneously with a significant activation to normal levels of postheparin plasma lipoprotein and hepatic lipases. Opposite effects were observed when gemfibrozil was discontinued and the patients were given placebo. No major harmful effects were observed.


Assuntos
Falência Renal Crônica/sangue , Lipase/deficiência , Lipase Lipoproteica/deficiência , Fígado/enzimologia , Ácidos Pentanoicos/uso terapêutico , Valeratos/uso terapêutico , Adulto , Idoso , Ensaios Clínicos como Assunto , Ativação Enzimática/efeitos dos fármacos , Feminino , Genfibrozila , Humanos , Falência Renal Crônica/tratamento farmacológico , Lipoproteínas/sangue , Masculino , Pessoa de Meia-Idade , Triglicerídeos/sangue
14.
Ann Clin Res ; 15(2): 92-4, 1983 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-6881908

RESUMO

A 34 year old woman is described in whom carditis, arthritis, fever, leukocytosis and a high sedimentation rate developed two weeks after a streptococcal infection. The patient also had the nephrotic syndrome and rapidly progressive renal insufficiency. The renal biopsy specimen showed acute extracapillary (crescentic) glomerulonephritis. The initial response to corticosteroid therapy was good, but later a slowly progressive renal function impairment was seen.


Assuntos
Glomerulonefrite/etiologia , Síndrome Nefrótica/etiologia , Febre Reumática/etiologia , Infecções Estreptocócicas/complicações , Tonsilite/complicações , Doença Aguda , Adulto , Sedimentação Sanguínea , Feminino , Humanos , Leucocitose/etiologia
15.
Acta Med Scand ; 208(4): 279-83, 1980.
Artigo em Inglês | MEDLINE | ID: mdl-7004092

RESUMO

The furosemide-induced increase in protein excretion, and its relations to 1) the size of protein molecules as reflected by three enzymes, and 2) glomerular filtration rate (GFR), plasma renin activity (PRA) and prostaglandin (PG) E2 and F2 alpha excretions were studied in 14 outpatients with normal renal function and 13 healthy males. Furosemide (120 mg) was given intravenously, and thereafter the protein excretion and the above parameters were monitored for 1--2 hours. In both groups, furosemide caused a transient increase in protein excretion. The excretion of the largest molecule, beta-glucuronidase, rose to 6.3-fold, while those of N-acetyl-beta-D-glucosaminidase and of the smallest molecule, alpha-amylase, increased by 91 and 37%, respectively. GFR increased, too, but markedly less than the protein excretion. PGE2 and PGF2 alpha excretions increased more than GFR and changed simultaneously with the excretion of proteins. Furosemide also caused a marked increase in PRA. This lasted, however, much longer than the rise in PG and protein excretion or GFR. The results suggest that the furosemide-induced increase in protein excretion is 1) related to the molecular size of proteins, 2) partly due to the rise in GFR, 3) simultaneous with the change in PG excretion. Our findings also agree with the view that furosemide causes changes in glomerular permeability.


Assuntos
Furosemida/farmacologia , Proteinúria/induzido quimicamente , Acetilglucosaminidase/metabolismo , Adulto , Feminino , Furosemida/administração & dosagem , Taxa de Filtração Glomerular , Glucuronidase/metabolismo , Humanos , Injeções Intravenosas , Masculino , Pessoa de Meia-Idade , Prostaglandinas E/metabolismo , Prostaglandinas F/metabolismo , Renina/sangue , alfa-Amilases/metabolismo
16.
Scand J Infect Dis ; 11(1): 85-7, 1979.
Artigo em Inglês | MEDLINE | ID: mdl-419374

RESUMO

A 26-year-old man developed pneumonia, hepatitis and biopsy-verified acute tubulointerstitial nephritis coinciding with a rise and fall of complement-fixing antibodies to Mycoplasma pneumoniae. M. pneumoniae antigenic material and complement (C3) in the renal interstitium were shown by immunohistochemical techniques. A causal relationship between M. pneumoniae infection and the renal lesion is suggested.


Assuntos
Infecções por Mycoplasma/complicações , Nefrite Intersticial/etiologia , Doença Aguda , Adulto , Hepatite/complicações , Humanos , Rim/patologia , Masculino , Infecções por Mycoplasma/patologia , Nefrite Intersticial/patologia , Pneumonia/complicações
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA